Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-15-037254
Filing Date
2015-06-15
Accepted
2015-06-16 05:10:16
Documents
1
Effectiveness Date
2015-06-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12332
  Complete submission text file 0001144204-15-037254.txt   13339
Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL a8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL a8 H4P 2R2 (514) 496-3220
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4
Type: D | Act: 33 | File No.: 021-241814 | Film No.: 15933102